FOXO Technologies 3Q 2026: Revenue $7M — 10-Q Summary
FOXO Technologies reported 3Q 2026 revenue of $7M, up 97.38% YoY, with earnings shifting from a loss to income. Growth was driven by higher RCHI revenue, including Medicare adjustments and rate changes. The Life Science Services segment saw revenue increase to $406,953. The Grifols acquisition remains pending regulatory approvals and financing.
